ENDOMETRIAL MUCINOUS ADENOCARCINOMA
Clinical trials for ENDOMETRIAL MUCINOUS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL MUCINOUS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL MUCINOUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Two drugs vs. one: new hope for Tough-to-Treat uterine cancer
Disease control Recruiting nowThis study is for people whose endometrial (uterine) cancer has returned after treatment. It compares two different immunotherapy approaches to see which is better at controlling the cancer. One group gets a single immunotherapy drug (nivolumab), while the other gets a combinatio…
Matched conditions: ENDOMETRIAL MUCINOUS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Blood test trial aims to predict uterine Cancer's return
Knowledge-focused Recruiting nowThis study is testing whether simple blood tests, called liquid biopsies, can predict if endometrial (uterine) cancer will come back after treatment. Researchers will collect blood samples from 1,000 women with endometrial cancer at different points during their treatment to trac…
Matched conditions: ENDOMETRIAL MUCINOUS ADENOCARCINOMA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC